TP53 Mutational Status Is a Potential Marker for Risk Stratification in Wilms Tumour with Diffuse Anaplasia
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TP53 Mutational Status Is a Potential Marker for Risk Stratification in Wilms Tumour with Diffuse Anaplasia
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 10, Pages e109924
Publisher
Public Library of Science (PLoS)
Online
2014-10-15
DOI
10.1371/journal.pone.0109924
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries
- (2013) Kathy Pritchard-Jones et al. LANCET ONCOLOGY
- Tissue Expression of MLH1, PMS2, MSH2, and MSH6 Proteins and Prognostic Value of Microsatellite Instability in Wilms Tumor: Experience of 45 Cases
- (2013) Gulden Diniz et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial
- (2012) K. Pritchard-Jones et al. ANNALS OF ONCOLOGY
- Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
- (2012) H. Thorvaldsdottir et al. BRIEFINGS IN BIOINFORMATICS
- Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations
- (2012) Tobias Rausch et al. CELL
- p53 Immunohistochemistry Expression in Wilms Tumor: A Prognostic Tool in the Detection of Tumor Aggressiveness
- (2012) Jan Franken et al. JOURNAL OF UROLOGY
- Children's Oncology Group's 2013 blueprint for research: Renal tumors
- (2012) Jeffrey S. Dome et al. PEDIATRIC BLOOD & CANCER
- The contribution of chest CT-scan at diagnosis in children with unilateral Wilms’ tumour. Results of the SIOP 2001 study
- (2011) Anne M.J.B. Smets et al. EUROPEAN JOURNAL OF CANCER
- Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in wilms tumor
- (2011) Richard D. Williams et al. GENES CHROMOSOMES & CANCER
- Links between mutant p53 and genomic instability
- (2011) Walter Hanel et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Twenty-five year follow-up of childhood Wilms tumor: A report from the Childhood Cancer Survivor Study
- (2011) Amanda M. Termuhlen et al. PEDIATRIC BLOOD & CANCER
- Next-generation sequencing: emerging lessons on the origins of human cancer
- (2010) Gerd P Pfeifer et al. CURRENT OPINION IN ONCOLOGY
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
- (2010) K. Wang et al. NUCLEIC ACIDS RESEARCH
- Secondary malignant neoplasms after Wilms tumor: An international collaborative study
- (2009) Norman E. Breslow et al. INTERNATIONAL JOURNAL OF CANCER
- Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma
- (2009) Paul A Northcott et al. NATURE GENETICS
- Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up
- (2008) T. Zenz et al. BLOOD
- Transcriptional control of human p53-regulated genes
- (2008) Todd Riley et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group
- (2007) Marcio Malogolowkin et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More